SuperworthaTYR PHARMA INC market cap ATYR
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $16.2M
- Highest close in our data
- $590.9M
- Sep 2025
aTYR PHARMA INC is worth $16.2M at the close on Oct 23, 2026, at $0.17 a share.
That is down 83% over the last year.
Its highest close in our data was $590.9M in Sep 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $16.2M | $16.2M | $101.9M | −78% |
| 2025 | $72.8M | $65.1M | $590.9M | −77% |
| 2024 | $313.9M | $102.8M | $313.9M | n/a |
Against its peers
Companies in Healthcare nearest aTYR PHARMA INC's size, closest first, today.
| Company | Market cap |
|---|---|
| ATYRaTYR PHARMA INC | $16.2M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on aTYR PHARMA INC
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.